Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age
Not Applicable
Not yet recruiting
- Conditions
- Aging
- Interventions
- Diagnostic Test: dosage
- Registration Number
- NCT06357923
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects \> 60 years of age respecting a male/female ratio = 1.
- Detailed Description
Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects \> 60 years of age respecting a male/female ratio = 1. After explanations and collection consent, collection of the patient's socio-demographic and medical characteristics and then carrying out a Peripheral venous blood sample (2 x 5ml tubes).
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Men and women over 60 years of age.
Exclusion Criteria
- Inability to Understand Consent,
- Non-Security Beneficiaries
- social, subjects protected by law, subjects deprived of liberty,
- history of breast cancer,
- brain tumor,
- melanoma,
- colon cancer,
- lung cancer,
- prostate cancer,
- lymphoma,
- myeloma,
- syndrome myelodysplastic/myeloproliferative,
- leukemia,
- history of radiation therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description evaluation of LAMP-2 protein expression dosage dosing of level expression of LAMP-2
- Primary Outcome Measures
Name Time Method Expression level of LAMP2 (protein and isoform A and B mRNA) day 0 dosage
- Secondary Outcome Measures
Name Time Method Presence of mutation in the "Oncomin Myeloid Reasearch Assay" gene panel targeting approximately 40 Different genes day 0 dosage
Trial Locations
- Locations (1)
Chu de Nice
🇫🇷Nice, France